Is a complete ASX/COV research report available?

No complete published report is available for asx/COV (ASX/COV) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ASX/COV (ASX/COV)

Australian Securities Exchange: ASX/COV · AUD

A$0.34

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-28 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ASX/COV analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	46.5M
Revenue (ttm)	2.6M
Net income (ttm)	-4M
EPS (ttm)	-A$0.03
Shares out	136.9M
Volume	8,119
Beta	0.41

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.6M
Net income (ttm): -4M
EPS (ttm): -A$0.03
Market cap: 46.5M

All ASX/COV indicators

Market & fundamental data

Available fields

151

Groups with data

Currency

AUD

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Enterprise value	AUD 37.1M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Medical Devices
Isin	AU0000288045
Last refreshed	2026-07-28
Market cap	AUD 46.5M
Price	AUD 0.34
Price currency	AUD
Sector	Healthcare
Sector PE	68.56
Sector PE Fwd	26.75
Sic	2835
Symbol	asx/COV
Website	https://www.cleodx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.67%
EV/Sales	14.48x
FCF yield	-5.42%
P/B ratio	5.27x
P/S ratio	18.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-151.15%
EBITDA Margin	-148.71%
Gross margin	100%
Gross Profit	AUD 2.6M
Gross Profit Growth	1,115.45%
Net Income	AUD -4M
Pretax Margin	-157.36%
Profit Margin	-157.36%
ROA	-27.12
ROCE	-43.88
ROE	-49.57
ROIC	-29.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-10.53%
Revenue Growth	1,115.45x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.29
Assets	AUD 10M
Cash	AUD 9.4M
Current Assets	AUD 9.6M
Current Liabilities	AUD 1.1M
Debt	AUD 0
Equity	AUD 8.8M
Liabilities	AUD 1.1M
Long Term Assets	AUD 361,063
Long Term Liabilities	AUD 0
Net Cash	AUD 9.4M
Net Cash By Market Cap	AUD 20.26
Net Cash Growth	28.94%
Net Debt Equity	AUD -1.07
Tangible Book Value	AUD 8.5M
Tangible Book Value Per Share	AUD 0.06
WACC	6.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.46
Net Working Capital	AUD -961,926
Quick ratio	8.39
Working Capital	AUD 8.5M
Working Capital Turnover	AUD 0.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-10.53%
200-day SMA	0.56
50-day SMA	0.5
50-day SMA vs 200-day SMA	50under200
All Time High	0.9
All Time High Change	-62.22%
All Time High Date	2026-01-19
All Time Low	0.14
All Time Low Change	142.86%
All Time Low Date	2024-01-30
ATR	0.03
Beta	0.41
Beta1y	0.18
Beta2y	0.32
Ch YTD	-43.8
High	0.35
High52	0.9
High52 Date	2026-01-19
High52ch	-62.22%
Low	0.34
Low52	0.31
Low52 Date	2026-07-24
Low52ch	9.68%
Ma50ch	-31.7%
Price vs 200-day SMA	-38.87%
RSI	27.31
RSI Monthly	43.65
RSI Weekly	34.29
Sharpe ratio	0.21x
Sortino ratio	0.43
Total Return	-10.54%
Tr YTD	-43.8
Tr1m	-28.42%
Tr1w	-4.23%
Tr3m	-50%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -3.9M
Operating margin	-151.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	83,252,085%
Shares Insiders	29.91%
Shares Out	136,862,085
Shares Qo Q	-9.62%
Shares Yo Y	10.54%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD -3M
Adjusted OCF	-2,949,850
Average Volume	250,544.35x
Bv Per Share	0.06
CAPEX	AUD -11,693
Ch1m	-28.42
Ch1w	-4.23
Ch1y	-10.53
Ch3m	-50
Ch6m	-56.69
Change	0%
Change From Open	-0.58
Close	0.34
Days Gap	0.59
Depreciation Amortization	62,412
Dollar Volume	2,760.5
Earnings Date	2026-08-26
EBIT	AUD -3.9M
EBITDA	AUD -3.8M
EPS	AUD -0.03
F Score	2
FCF	AUD -2.5M
FCF EV Yield	-6.79x
FCF Per Share	AUD -0.02
Financing CF	4,635,436
Fiscal Year End	June
Founded	2,021
Investing CF	-11,693
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Ma150	0.57
Ma150ch	-40.4%
Ma20	0.43
Ma20ch	-21.17%
Net CF	2,115,438
Next Earnings Date	2026-08-26
Open	0.34
Position In Range	0
Ppne	27,730
Price Date	2026-07-28
Ptbv Ratio	5.48
Relative Volume	0.03x
Revenue	2,562,322x
SBC By Revenue	17.23x
Share Based Comp	441,545
Tr6m	-56.69%
Volume	8,119
Z Score	26.85

ASX/COV (ASX/COV)

Coverage state: Market snapshot only — no published research

Generate the first ASX/COV analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/COV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/COV indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ASX/COV

Frequently asked questions